Literature DB >> 11737390

Cushing's syndrome secondary to inhaled corticosteroids mimicking HIV-associated lipodystrophy.

C W le Roux1, M A Beckles, G M Besser, A J Pinching, A G Davison.   

Abstract

We report the case of an asthmatic man with HIV infection who was initially diagnosed with HIV treatment-associated lipodystrophy. Further investigations showed he had Cushing's syndrome secondary to 1600 microg of budesonide dry powder inhaler. Cushing's syndrome has not been reported previously on this normal dose of inhaled budesonide.

Entities:  

Mesh：

Substances：

Year:  2001        PMID： 11737390     DOI： 10.1046/j.1468-1293.2001.00058.x

Source DB:  PubMed          Journal:  HIV Med        ISSN： 1464-2662            Impact factor:   3.180


  3 in total

1.  Iatrogenic Cushing Syndrome from Interaction Between Ritonavir and Oral Budesonide During Direct Acting Antiviral Hepatitis C Therapy.

Authors:  Sern Wei Yeoh
Journal:  J Clin Exp Hepatol       Date:  2016-05-20

Review 2.  Inhaled corticosteroid use in HIV-positive individuals taking protease inhibitors: a review of pharmacokinetics, case reports and clinical management.

Authors:  P Saberi; T Phengrasamy; D P Nguyen
Journal:  HIV Med       Date:  2013-04-16       Impact factor: 3.180

3.  Iatrogenic Cushing syndrome and adrenal insufficiency during concomitant therapy with ritonavir and fluticasone.

Authors:  Narendranath Epperla; Fergus McKiernan
Journal:  Springerplus       Date:  2015-08-27
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.